Atlas Trials

Relapsed Hematologic Malignancy

11 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed Hematologic Malignancy

RecordFirmDate
A Study of Tazemetostat in Combination With Various Treatments in Participants With Blood Cancer. (NCT05205252)Epizyme, Inc.2021-12-22
Impact of the Coordinated Intervention of the Healthcare Facilities Pharmacist and the Dispensary Pharmacist on the Care Pathway for Cancer Patients Treated With Oral Therapy (NCT04327583)Institut Cancerologie de l'Ouest2021-04-07
Infusion of Donor Derived Cytokine Induced Killer (CIK) Cells in Hematological Patients Relapsed After Haploidentical Stem Cell Transplant (NCT03821519)A.O. Ospedale Papa Giovanni XXIII2019-01-13
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies (NCT03560882)Joaquina Baranda2018-07-19
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant (NCT03413800)Ciusss de L'Est de l'Île de Montréal2018-02-12
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL) (NCT03328078)Curis, Inc.2017-12-28
Extended Analysis for Leukemia/Lymphoma Treatment (NCT03096821)Medical University of Vienna2015-09-01

Track Relapsed Hematologic Malignancy automatically

Every clearance here is in the API, with alerts when new ones post.